π
|
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
7 auth.
R. D'Agostino,
R. Vasan,
M. Pencina,
P. Wolf,
M. Cobain,
J. Massaro,
...
W. Kannel
|
12 |
2008 |
12 π
|
π¦
|
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
M. Pencina,
R. B. D' Agostino,
R. B. D' Agostino,
R. Vasan
|
12 |
2008 |
12 π¦
|
π
|
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
8 auth.
E. Steyerberg,
A. Vickers,
N. Cook,
T. Gerds,
M. Gonen,
N. Obuchowski,
...
M. Pencina,
M. Kattan
|
11 |
2010 |
11 π
|
π
|
Vitamin D Deficiency and Risk of Cardiovascular Disease
10 auth.
Thomas J. Wang,
M. Pencina,
S. Booth,
P. Jacques,
E. Ingelsson,
Katherine J. Lanier,
...
E. Benjamin,
R. D'Agostino,
M. Wolf,
R. Vasan
|
11 |
2008 |
11 π
|
π¦
|
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
M. Pencina,
R. D'Agostino,
E. Steyerberg
|
11 |
2011 |
11 π¦
|
π
|
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
19 auth.
Jennifer B. Green,
M. A. Bethel,
P. Armstrong,
J. Buse,
S. Engel,
Jyotsna Garg,
R. Josse,
K. Kaufman,
J. Koglin,
S. Korn,
...
J. Lachin,
Darren K Mcguire,
M. Pencina,
E. Standl,
P. Stein,
S. Suryawanshi,
F. Van de Werf,
E. Peterson,
R. Holman
|
11 |
2015 |
11 π
|
π
|
Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study
9 auth.
G. Mitchell,
Shih-Jen Hwang,
R. Vasan,
M. Larson,
M. Pencina,
N. Hamburg,
...
J. Vita,
D. Levy,
E. Benjamin
|
10 |
2010 |
10 π
|
π¦
|
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation
M. Pencina,
R. D'Agostino
|
10 |
2004 |
10 π¦
|
π¬
|
On the Cβstatistics for evaluating overall adequacy of risk prediction procedures with censored survival data
H. Uno,
T. Cai,
M. Pencina,
R. DβAgostino,
Lee-Jen Wei
|
10 |
2011 |
10 π¬
|
π
|
One-year cardiovascular event rates in outpatients with atherothrombosis.
12 auth.
P. Steg,
Deepak L. Bhatt,
P. Wilson,
R. D'Agostino,
E. Ohman,
J. RΓΆther,
...
C. Liau,
A. Hirsch,
J. Mas,
Y. Ikeda,
M. Pencina,
S. Goto
|
10 |
2007 |
10 π
|
π
|
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography.
21 auth.
J. Min,
J. Leipsic,
M. Pencina,
D. Berman,
B. Koo,
Carl-Edward Van Mieghem,
A. Erglis,
F. Lin,
A. Dunning,
Patricia Apruzzese,
...
M. Budoff,
Jason H. Cole,
F. Jaffer,
M. Leon,
M. Leon,
J. Malpeso,
G. Mancini,
SeungβJung Park,
R. Schwartz,
L. Shaw,
L. Mauri
|
10 |
2012 |
10 π
|
π
|
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
16 auth.
R. Schnabel,
L. Sullivan,
D. Levy,
M. Pencina,
J. Massaro,
R. D'Agostino,
C. NewtonβCheh,
J. Yamamoto,
J. Magnani,
T. Tadros,
...
W. Kannel,
Thomas J. Wang,
P. Ellinor,
P. Wolf,
R. Vasan,
E. Benjamin
|
9 |
2009 |
9 π
|
π
|
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial
19 auth.
J. Rosenstock,
V. Perkovic,
O. Johansen,
M. Cooper,
S. Kahn,
N. Marx,
J. Alexander,
M. Pencina,
R. Toto,
C. Wanner,
...
B. Zinman,
H. Woerle,
David Baanstra,
E. Pfarr,
S. Schnaidt,
T. Meinicke,
J. George,
M. von Eynatten,
D. McGuire
|
9 |
2019 |
9 π
|
π
|
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
27 auth.
Raymond H Chan,
B. Maron,
I. Olivotto,
M. Pencina,
G. Assenza,
Tammy S. Haas,
J. Lesser,
C. Gruner,
A. Crean,
H. Rakowski,
J. Udelson,
E. Rowin,
M. Lombardi,
F. Cecchi,
B. Tomberli,
...
P. Spirito,
Francesco Formisano,
E. Biagini,
C. Rapezzi,
C. D. De Cecco,
C. Autore,
E. Cook,
S. Hong,
C. Gibson,
W. Manning,
E. Appelbaum,
M. Maron
|
9 |
2014 |
9 π
|
π¦
|
Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study
M. Pencina,
R. D'Agostino,
M. Larson,
J. Massaro,
R. Vasan
|
9 |
2009 |
9 π¦
|